TABLE 1.
Parameter | Virus
|
|
---|---|---|
PrV-Ka | PrV-ΔUL51F | |
Mean time to death (h)a | 50.0 (1.9) | 64 (2.1) |
Clinical symptoms (days p.i.)b | ||
1 | 0 | 0 |
2 | +++ | + |
3 | † | +++ |
Immunohistochemistry (days p.i.)c | ||
Nasal cavity | 1 | 1 |
First-order neurons | 1 | 2 |
Second-order neurons | 2 | 3 |
Third-order neurons | −d | − |
Averages calculated for 10 animals each. Standard deviations are indicated in parentheses.
Clinical symptoms were measured as follows: 0, clinically normal mice; +, slight depression, hunched position, ruffled hair coat; ++, apathy, anorexia, moderate dyspnea, slight facial pruritus; +++, severe attacks of excitation, self-mutilation, skin erosions, heavy dyspnea; †, animals moribund or dead.
Immunohistochemistry was measured as the time in days p.i. of first antigen detection at the following different neuronal levels of the trigeminal pathway: nasal cavity in respiratory mucosal epithelium, first-order neurons in the trigeminal ganglion, second-order neurons in the spinal trigeminal nucleus (Sp5), and third-order neurons in the ectorhinal cortex.
−, no infected cells detectable.